230 related articles for article (PubMed ID: 2997300)
41. 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis.
Cadranel J; Garabedian M; Milleron B; Guillozo H; Akoun G; Hance AJ
J Clin Invest; 1990 May; 85(5):1588-93. PubMed ID: 2159024
[TBL] [Abstract][Full Text] [Related]
42. The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells.
Manolagas SC; Provvedini DM; Murray EJ; Tsoukas CD; Deftos LJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):394-400. PubMed ID: 3013918
[TBL] [Abstract][Full Text] [Related]
43. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes.
Provvedini DM; Manolagas SC
J Clin Endocrinol Metab; 1989 Apr; 68(4):774-9. PubMed ID: 2564005
[TBL] [Abstract][Full Text] [Related]
44. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene.
Hewison M; Rut AR; Kristjansson K; Walker RE; Dillon MJ; Hughes MR; O'Riordan JL
Clin Endocrinol (Oxf); 1993 Dec; 39(6):663-70. PubMed ID: 8287584
[TBL] [Abstract][Full Text] [Related]
45. The molecular basis for resistance to 1,25-dihydroxyvitamin D: studies in cells cultured from patients with hereditary hypocalcemic 1,25(OH)2D3-resistant rickets.
Eil C; Liberman UA; Marx SJ
Adv Exp Med Biol; 1986; 196():407-22. PubMed ID: 3012982
[No Abstract] [Full Text] [Related]
46. Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes.
Tobler A; Gasson J; Reichel H; Norman AW; Koeffler HP
J Clin Invest; 1987 Jun; 79(6):1700-5. PubMed ID: 3034980
[TBL] [Abstract][Full Text] [Related]
47. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol.
Brennan A; Katz DR; Nunn JD; Barker S; Hewison M; Fraher LJ; O'Riordan JL
Immunology; 1987 Aug; 61(4):457-61. PubMed ID: 2832307
[TBL] [Abstract][Full Text] [Related]
48. Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: immunologic crossreactivity and inverse regulation with the vitamin D receptor.
Yu XP; Hustmyer FG; Garvey WT; Manolagas SC
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8347-51. PubMed ID: 1656441
[TBL] [Abstract][Full Text] [Related]
49. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells.
Costa EM; Blau HM; Feldman D
Endocrinology; 1986 Nov; 119(5):2214-20. PubMed ID: 3021437
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
[TBL] [Abstract][Full Text] [Related]
51. The influence of calciotrophic hormones on lymphocyte transformation and interleukin-2 production in human mononuclear cells.
Smith J; Jenkins AS; Caine S; Boyle IT
J Clin Lab Immunol; 1990 Oct; 33(2):49-54. PubMed ID: 1967065
[TBL] [Abstract][Full Text] [Related]
52. Expression of 1,25(OH)2D3 receptors on alveolar lymphocytes from patients with pulmonary granulomatous diseases.
Biyoudi-Vouenze R; Cadranel J; Valeyre D; Milleron B; Hance AJ; Soler P
Am Rev Respir Dis; 1991 Jun; 143(6):1376-80. PubMed ID: 1646583
[TBL] [Abstract][Full Text] [Related]
53. 1,25-Dihydroxyvitamin D3 receptor measurement in primary renal cell carcinomas and autologous normal kidney tissue.
Trydal T; Bakke A; Aksnes L; Aarskog D
Cancer Res; 1988 May; 48(9):2458-61. PubMed ID: 2833346
[TBL] [Abstract][Full Text] [Related]
54. Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.
Liberman UA; Eil C; Marx SJ
J Clin Invest; 1983 Feb; 71(2):192-200. PubMed ID: 6296200
[TBL] [Abstract][Full Text] [Related]
55. Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor.
Barsony J; McKoy W; DeGrange DA; Liberman UA; Marx SJ
J Clin Invest; 1989 Jun; 83(6):2093-101. PubMed ID: 2542381
[TBL] [Abstract][Full Text] [Related]
56. Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures.
Rut AR; Hewison M; Kristjansson K; Luisi B; Hughes MR; O'Riordan JL
Clin Endocrinol (Oxf); 1994 Nov; 41(5):581-90. PubMed ID: 7828346
[TBL] [Abstract][Full Text] [Related]
57. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells.
Kizaki M; Norman AW; Bishop JE; Lin CW; Karmakar A; Koeffler HP
Blood; 1991 Mar; 77(6):1238-47. PubMed ID: 1705836
[TBL] [Abstract][Full Text] [Related]
58. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
59. Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of hormone-receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation.
Liberman UA; Eil C; Marx SJ
J Clin Endocrinol Metab; 1986 Jan; 62(1):122-6. PubMed ID: 2999175
[TBL] [Abstract][Full Text] [Related]
60. Mononuclear cells from human neonates are partially resistant to the action of 1,25-dihydroxyvitamin D.
Ravid A; Koren R; Rotem C; Amir Y; Reisner S; Novogrodsky A; Liberman UA
J Clin Endocrinol Metab; 1988 Oct; 67(4):755-9. PubMed ID: 2843561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
